[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"case:lead-pharma-medicine-bv-09172969:header:guest:personal:":3,"case:lead-pharma-medicine-bv-09172969:overview:guest:personal::{}":79},{"id":4,"slug":5,"name":6,"trade_names":7,"status":8,"procedure":9,"procedure_type":10,"insolvency_number":29,"case_number":29,"declared_on":30,"terminated_on":31,"termination_reason":32,"kvk_number":33,"legal_form":34,"sbi":14,"court":37,"judge":40,"judge_source":41,"curator":42,"location":46,"counts":56,"pages":61,"follower_count":60,"report_count":57,"last_report_on":73,"last_update_at":74,"freshness":75,"linked":78},"01M3SJFSJCWBFFNRZ7ERDWZQ0C","lead-pharma-medicine-bv-09172969","Lead Pharma Medicine B.V.",[],"terminated","bankruptcy",{"id":11,"key":9,"family":12,"name":13,"short_name":14,"legal_basis":15,"features":19},"01M3Y8CPCPT53NPXHK39BWK1QY","insolvency","Faillissement",null,{"name":16,"provision":17,"url":18},"Faillissementswet","Titel I (art. 1 e.v.)","https:\u002F\u002Fwetten.overheid.nl\u002FBWBR0001860",[20,21,22,23,24,25,26,27,28],"reports","financials","creditors","assets","investigations","curator_workspace","appointments","court_decisions","portfolio_monitoring","F.01\u002F25\u002F159","2025-06-17","2026-09-29","lack_of_assets","09172969",{"value":35,"source":36},"BV","cir",{"name":38,"slug":39,"location":14},"Rechtbank Oost-Brabant","oost-brabant","mr. S.C.E.F. Moulen Janssen",{"type":36,"report_number":14,"published_on":14},{"name":43,"slug":44,"law_firm":14,"city":14,"verified":45},"mr. D.P. Schalken","dp-schalken",false,{"street":47,"house_number":48,"addition":49,"postal_code":50,"city":51,"municipality":51,"province":52,"lat":53,"lng":54,"kind":55,"source":36},"Kloosterstraat","9","RK","5349AB","Oss","Noord-Brabant",51.760717,5.533719,"business",{"reports":57,"documents":58,"assets":59,"investigations":60,"news":60},9,13,6,0,{"overview":62,"reports":64,"financials":65,"investigations":66,"assets":67,"timeline":68,"documents":69,"news":70,"company":71,"compare":72},{"index":63,"ads":63},true,{"index":63,"ads":63},{"index":63,"ads":63},{"index":45,"ads":45},{"index":63,"ads":45},{"index":63,"ads":45},{"index":63,"ads":45},{"index":45,"ads":45},{"index":63,"ads":45},{"index":45,"ads":45},"2026-08-11","2026-10-04T17:34:33+00:00",{"last_checked_at":76,"last_reconciled_at":76,"stale":45,"status":77},"2026-10-11T04:06:37+00:00","current",{"continued_from":14,"continued_as":14},{"data":80},{"summary":81,"changes":148,"kpis":238,"topics":269,"topics_report_number":105,"topics_report_date":106,"processing":14,"timeline":336,"documents":393,"sources":409,"curator_update":14,"news":411,"auctions":412,"auction_count":60},{"kind":82,"category":82,"sentences":83,"facts":127,"published_at":147},"template",[84,89,92,96,99,109,115,121],{"key":85,"params":86,"facts":87},"declared",{"procedure":9,"date":30,"court":38,"number":29},[88],"procedure",{"key":8,"params":90,"facts":91},{"date":31},[8],{"key":93,"params":94,"facts":95},"curator",{"name":43},[93],{"key":20,"params":97,"facts":98},{"count":57,"number":14,"date":73},[20],{"key":100,"params":101,"facts":107},"value",{"field":102,"value":103,"state":104,"qualifier":14,"number":105,"date":106},"estate_assets",315857.06,"known",4,"2026-04-08",[108],"value_estate_assets",{"key":100,"params":110,"facts":113},{"field":111,"value":112,"state":104,"qualifier":14,"number":105,"date":106},"concurrent_claims",680175.99,[114],"value_concurrent_claims",{"key":100,"params":116,"facts":119},{"field":117,"value":118,"state":104,"qualifier":14,"number":105,"date":106},"creditor_count",21,[120],"value_creditor_count",{"key":100,"params":122,"facts":125},{"field":123,"value":124,"state":104,"qualifier":14,"number":105,"date":106},"preferential_claims",580086.57,[126],"value_preferential_claims",{"company":128,"procedure":130,"terminated":131,"curator":132,"reports":133,"value_estate_assets":134,"value_concurrent_claims":138,"value_creditor_count":141,"value_preferential_claims":144},{"category":129},"official",{"category":129},{"category":129},{"category":129},{"category":129},{"category":135,"value_id":136,"reference_id":137},"automated",45712,372179,{"category":135,"value_id":139,"reference_id":140},13651,318122,{"category":135,"value_id":142,"reference_id":143},13650,318121,{"category":135,"value_id":145,"reference_id":146},13652,318123,"2026-10-09T07:57:19+00:00",{"from":149,"to":153,"count":155,"groups":156},{"id":150,"number":151,"published_on":152},"01M3SJFZZX1K9WBY6WZ9W86CVW",3,"2026-01-14",{"id":154,"number":105,"published_on":106},"01M3SJG4ZHENMD35XVB72FSVJQ",7,{"new":157,"changed":158,"completed":224,"ongoing":236,"no_longer_mentioned":237},[],[159,180,192,204,212,219],{"kind":160,"field":111,"change":161,"from":162,"to":164,"delta":165,"delta_ratio":166,"source":167},"amount","changed",{"value":163,"state":104,"qualifier":14},669975.99,{"value":112,"state":104,"qualifier":14},10200,0.0152,{"id":140,"category":135,"method":168,"source_type":169,"document":170,"page":175,"section":176,"excerpt":177,"certainty":178,"curator_verified_at":14,"processed_at":179},"deterministic","cir_report",{"id":171,"title":172,"report_number":105,"report_date":106,"published_on":106,"page_count":173,"url":174,"available":63},"01M3SJG6EV72GZJ4NWXZ6V4RQB","Verslag: 08-04-2026",17,"https:\u002F\u002Ffaillissement.app\u002Fdocuments\u002F01M3SJG6EV72GZJ4NWXZ6V4RQB.pdf",15,"8.6 Bedrag concurrente crediteuren","€ 662.535,77 Toelichting Van dit bedrag bestaat EUR 625.393,20 uit voorafgaand aan faillietverklaring verschuldigde huurpenningen. De huurbetaling w as als gevolg van een eind 2024 gemaakte afspraak met de verhuurder uitgesteld.",0.95,"2026-10-02T18:43:03+00:00",{"kind":181,"field":117,"change":161,"from":182,"to":184,"delta":185,"delta_ratio":186,"source":187},"count",{"value":183,"state":104,"qualifier":14},20,{"value":118,"state":104,"qualifier":14},1,0.05,{"id":143,"category":135,"method":168,"source_type":169,"document":188,"page":189,"section":190,"excerpt":191,"certainty":178,"curator_verified_at":14,"processed_at":179},{"id":171,"title":172,"report_number":105,"report_date":106,"published_on":106,"page_count":173,"url":174,"available":63},14,"8.5 Aantal concurrente crediteuren","7",{"kind":193,"topic":194,"change":161,"from":195,"to":196,"source":197},"topic","bookkeeping_duty","investigating","mentioned",{"id":198,"category":135,"method":168,"source_type":169,"document":199,"page":200,"section":201,"excerpt":202,"certainty":203,"curator_verified_at":14,"processed_at":179},318135,{"id":171,"title":172,"report_number":105,"report_date":106,"published_on":106,"page_count":173,"url":174,"available":63},11,"7.1 Boekhoudplicht","Voldaan.",0.5,{"kind":193,"topic":205,"change":161,"from":195,"to":196,"source":206},"director_liability",{"id":207,"category":135,"method":168,"source_type":169,"document":208,"page":209,"section":210,"excerpt":211,"certainty":203,"curator_verified_at":14,"processed_at":179},318136,{"id":171,"title":172,"report_number":105,"report_date":106,"published_on":106,"page_count":173,"url":174,"available":63},12,"7.5 Onbehoorlijk bestuur","Toelichting Er is geen sprake van onbehoorlijk bestuur. De gemaakte intercompany-afspraken over de toebedeling van kosten en activa binnen het concern w erd achterhaald door het uitgesproken faillissement van Lead Pharma Holding B.V.",{"kind":193,"topic":213,"change":161,"from":195,"to":196,"source":214},"paulianas",{"id":215,"category":135,"method":168,"source_type":169,"document":216,"page":209,"section":217,"excerpt":218,"certainty":203,"curator_verified_at":14,"processed_at":179},318137,{"id":171,"title":172,"report_number":105,"report_date":106,"published_on":106,"page_count":173,"url":174,"available":63},"7.6 Paulianeus handelen","Nee Toelichting Er is geen sprake van paulianeus handelen.",{"kind":193,"topic":220,"change":161,"from":195,"to":196,"source":221},"legality_review",{"id":222,"category":135,"method":168,"source_type":169,"document":223,"page":200,"section":201,"excerpt":202,"certainty":203,"curator_verified_at":14,"processed_at":179},318138,{"id":171,"title":172,"report_number":105,"report_date":106,"published_on":106,"page_count":173,"url":174,"available":63},[225],{"kind":193,"topic":226,"change":227,"from":196,"to":227,"source":228},"causes_investigation","completed",{"id":229,"category":135,"method":168,"source_type":169,"document":230,"page":231,"section":232,"excerpt":233,"certainty":234,"curator_verified_at":14,"processed_at":235},134802,{"id":171,"title":172,"report_number":105,"report_date":106,"published_on":106,"page_count":173,"url":174,"available":63},5,"1.5 Oorzaak faillissement","Tot heden is de curator het volgende gebleken uit gesprekken met het bestuur en betrokkenen, maar dit vormt geen conclusie. Lead Pharma Medicine B.V. exploiteert een farmaceutisch onderzoeks- en ontw ikkelbedrijf. Daartoe verricht zij onderzoek naar nieuw e medicijnen ter genezing van kanker en auto-immuunziekten. Medicijnonderzoek is een langdurig en kostbaar traject. Van een idee naar verkoop du",0.7,"2026-09-30T16:31:29+00:00",[],[],{"values":239,"reports":268},[240,251,255,261,265],{"field":102,"kind":160,"value":103,"state":104,"qualifier":14,"as_of":106,"category":135,"report_number":105,"report_date":106,"source":241,"previous":248,"delta":250,"curator":14,"processing":45,"correction_pending":45,"conflict":14},{"id":137,"category":135,"method":168,"source_type":169,"document":242,"page":59,"section":246,"excerpt":247,"certainty":178,"curator_verified_at":14,"processed_at":74},{"id":243,"title":244,"report_number":105,"report_date":106,"published_on":106,"page_count":57,"url":245,"available":63},"01M3SJG4YYAPBHX0ZT5CMQ61T4","Financieel verslag 08-04-2026","https:\u002F\u002Ffaillissement.app\u002Fdocuments\u002F01M3SJG4YYAPBHX0ZT5CMQ61T4.pdf","financial_statement_a","Totaal baten                                         € 315.857,06                      € 54.548,53",{"value":249,"state":104,"report_number":151,"report_date":152},315647.65,209.41,{"field":111,"kind":160,"value":112,"state":104,"qualifier":14,"as_of":106,"category":135,"report_number":105,"report_date":106,"source":252,"previous":254,"delta":165,"curator":14,"processing":45,"correction_pending":45,"conflict":14},{"id":140,"category":135,"method":168,"source_type":169,"document":253,"page":175,"section":176,"excerpt":177,"certainty":178,"curator_verified_at":14,"processed_at":179},{"id":171,"title":172,"report_number":105,"report_date":106,"published_on":106,"page_count":173,"url":174,"available":63},{"value":163,"state":104,"report_number":151,"report_date":152},{"field":123,"kind":160,"value":124,"state":104,"qualifier":14,"as_of":106,"category":135,"report_number":105,"report_date":106,"source":256,"previous":260,"delta":60,"curator":14,"processing":45,"correction_pending":45,"conflict":14},{"id":146,"category":135,"method":168,"source_type":169,"document":257,"page":189,"section":258,"excerpt":259,"certainty":178,"curator_verified_at":14,"processed_at":179},{"id":171,"title":172,"report_number":105,"report_date":106,"published_on":106,"page_count":173,"url":174,"available":63},"8.2 Pref. vord. van de fiscus","€ 193.905,00 Toelichting Dit bedrag zal nog verder oplopen.",{"value":124,"state":104,"report_number":151,"report_date":152},{"field":117,"kind":181,"value":118,"state":104,"qualifier":14,"as_of":106,"category":135,"report_number":105,"report_date":106,"source":262,"previous":264,"delta":185,"curator":14,"processing":45,"correction_pending":45,"conflict":14},{"id":143,"category":135,"method":168,"source_type":169,"document":263,"page":189,"section":190,"excerpt":191,"certainty":178,"curator_verified_at":14,"processed_at":179},{"id":171,"title":172,"report_number":105,"report_date":106,"published_on":106,"page_count":173,"url":174,"available":63},{"value":183,"state":104,"report_number":151,"report_date":152},{"field":266,"kind":181,"value":14,"state":267,"qualifier":14,"as_of":14,"category":14,"report_number":14,"report_date":14,"source":14,"previous":14,"delta":14,"curator":14,"processing":45,"correction_pending":45,"conflict":14},"employee_count","not_mentioned",{"count":57,"next":14},[270,277,280,287,294,302,309,312,319,322,325,333],{"topic":271,"investigation":45,"state":196,"category":135,"source":272},"lease_contracts",{"id":273,"category":135,"method":168,"source_type":169,"document":274,"page":105,"section":275,"excerpt":276,"certainty":203,"curator_verified_at":14,"processed_at":179},318127,{"id":171,"title":172,"report_number":105,"report_date":106,"published_on":106,"page_count":173,"url":174,"available":63},"1.4 Huur","Afgelopen verslagperiode is een schikking bereikt met de verhuurder over de oplevering, de vaststelling van de diverse vorderingen en de afrekening van 4 de zekerhedenpositie.",{"topic":226,"investigation":63,"state":227,"category":135,"source":278},{"id":229,"category":135,"method":168,"source_type":169,"document":279,"page":231,"section":232,"excerpt":233,"certainty":234,"curator_verified_at":14,"processed_at":235},{"id":171,"title":172,"report_number":105,"report_date":106,"published_on":106,"page_count":173,"url":174,"available":63},{"topic":281,"investigation":45,"state":196,"category":135,"source":282},"employees",{"id":283,"category":135,"method":168,"source_type":169,"document":284,"page":59,"section":285,"excerpt":286,"certainty":203,"curator_verified_at":14,"processed_at":235},134803,{"id":171,"title":172,"report_number":105,"report_date":106,"published_on":106,"page_count":173,"url":174,"available":63},"2.3 Ontslagaanzegging","Datum Aantal Toelichting 20-6-2025 18 totaal 18",{"topic":288,"investigation":45,"state":196,"category":135,"source":289},"asset_sales",{"id":290,"category":135,"method":168,"source_type":169,"document":291,"page":59,"section":292,"excerpt":293,"certainty":203,"curator_verified_at":14,"processed_at":235},134804,{"id":171,"title":172,"report_number":105,"report_date":106,"published_on":106,"page_count":173,"url":174,"available":63},"3.1 Onroerende zaken","Beschrijving Verkoopopbr. Hypotheek Boedelbijdr. N.v.t. totaal € 0,00 € 0,00 Toelichting onroerende zaken",{"topic":295,"investigation":45,"state":196,"category":135,"source":296},"receivables_collection",{"id":297,"category":135,"method":168,"source_type":169,"document":298,"page":299,"section":300,"excerpt":301,"certainty":203,"curator_verified_at":14,"processed_at":235},134809,{"id":171,"title":172,"report_number":105,"report_date":106,"published_on":106,"page_count":173,"url":174,"available":63},8,"4.1 Debiteuren","Beschrijving Omvang Opbrengst Boedelbijdr. N.v.t. totaal € 0,00 € 0,00 € 0,00 Toelichting debiteuren Failliet is afhankelijk van investeerders en overheidsinstellingen. Er w erden geen facturen gestuurd.",{"topic":303,"investigation":45,"state":196,"category":135,"source":304},"security_rights",{"id":305,"category":135,"method":168,"source_type":169,"document":306,"page":57,"section":307,"excerpt":308,"certainty":203,"curator_verified_at":14,"processed_at":179},318129,{"id":171,"title":172,"report_number":105,"report_date":106,"published_on":106,"page_count":173,"url":174,"available":63},"5.3 Beschrijving zekerheden","Er is een schikking bereikt met de pandhouder c.q. verhuurder, die inmiddels ook is uitgevoerd. Dit is dus afgerond.",{"topic":194,"investigation":63,"state":196,"category":135,"source":310},{"id":198,"category":135,"method":168,"source_type":169,"document":311,"page":200,"section":201,"excerpt":202,"certainty":203,"curator_verified_at":14,"processed_at":179},{"id":171,"title":172,"report_number":105,"report_date":106,"published_on":106,"page_count":173,"url":174,"available":63},{"topic":313,"investigation":63,"state":227,"category":135,"source":314},"annual_accounts_filing",{"id":315,"category":135,"method":168,"source_type":169,"document":316,"page":209,"section":317,"excerpt":318,"certainty":234,"curator_verified_at":14,"processed_at":235},134817,{"id":171,"title":172,"report_number":105,"report_date":106,"published_on":106,"page_count":173,"url":174,"available":63},"7.2 Depot jaarrekeningen","De jaarrekening 2023 is gedeponeerd op 4 juli 2024.",{"topic":205,"investigation":63,"state":196,"category":135,"source":320},{"id":207,"category":135,"method":168,"source_type":169,"document":321,"page":209,"section":210,"excerpt":211,"certainty":203,"curator_verified_at":14,"processed_at":179},{"id":171,"title":172,"report_number":105,"report_date":106,"published_on":106,"page_count":173,"url":174,"available":63},{"topic":213,"investigation":63,"state":196,"category":135,"source":323},{"id":215,"category":135,"method":168,"source_type":169,"document":324,"page":209,"section":217,"excerpt":218,"certainty":203,"curator_verified_at":14,"processed_at":179},{"id":171,"title":172,"report_number":105,"report_date":106,"published_on":106,"page_count":173,"url":174,"available":63},{"topic":326,"investigation":63,"state":196,"category":135,"source":327},"proceedings",{"id":328,"category":135,"method":168,"source_type":169,"document":329,"page":330,"section":331,"excerpt":332,"certainty":203,"curator_verified_at":14,"processed_at":235},134820,{"id":171,"title":172,"report_number":105,"report_date":106,"published_on":106,"page_count":173,"url":174,"available":63},16,"9.1 Naam wederpartijen","Er is niet gebleken van procedures.",{"topic":220,"investigation":63,"state":196,"category":135,"source":334},{"id":222,"category":135,"method":168,"source_type":169,"document":335,"page":200,"section":201,"excerpt":202,"certainty":203,"curator_verified_at":14,"processed_at":179},{"id":171,"title":172,"report_number":105,"report_date":106,"published_on":106,"page_count":173,"url":174,"available":63},[337,347,352,360,367],{"id":338,"type":339,"group":88,"category":129,"occurred_at":340,"detected_at":341,"date_basis":342,"payload":343,"from_case":14,"source":14},"01M3SJFSMMPXYSF57HT2H28SJG","publication_added","2026-09-30T00:00:00+00:00","2026-09-30T16:31:13+00:00","source",{"publication_id":344,"type":345,"description":346},"01M3SJFSM4FTZCD4RW2MVXCTP3","termination","Opheffing faillissement wegens gebrek aan baten op 29 september 2026",{"id":348,"type":349,"group":88,"category":129,"occurred_at":350,"detected_at":341,"date_basis":342,"payload":351,"from_case":14,"source":14},"01M3SJFSMQX323HXVS9X469T2G","case_terminated","2026-09-29T00:00:00+00:00",{"status":8,"reason":32},{"id":353,"type":354,"group":20,"category":129,"occurred_at":355,"detected_at":356,"date_basis":342,"payload":357,"from_case":14,"source":14},"01M3SJG819ESJGTAAKMA93J97Z","report_published","2026-08-11T12:00:00+00:00","2026-09-30T16:31:28+00:00",{"report_id":358,"report_number":14,"report_date":73,"title":359,"is_final":45},"01M3SJG6FEAWMH3848H04YH4D5","Financieel verslag  04-08-2026",{"id":361,"type":339,"group":88,"category":129,"occurred_at":362,"detected_at":341,"date_basis":342,"payload":363,"from_case":14,"source":14},"01M3SJFSMHNTZBKNQ3HZNMJF2C","2026-05-13T00:00:00+00:00",{"publication_id":364,"type":365,"description":366},"01M3SJFSM3Z6MEWKZGNM4HV5W9","other","Vereenvoudigde afwikkeling van het faillissement",{"id":368,"type":369,"group":370,"category":135,"occurred_at":371,"detected_at":74,"date_basis":342,"payload":372,"from_case":14,"source":14},"01M43ZPMHXVZN6717B8YS6EP76","financial_changed","financial","2026-04-08T12:00:00+00:00",{"from_report":373,"to_report":374,"from_number":151,"to_number":105,"from_date":152,"to_date":106,"fields":375},"01M3SJG1NNPSYYN830PZWANSXG","01M3SJG386F9XHFPVQ99ZCXF6P",[376,379,386],{"field":102,"from":377,"to":378,"delta":250},{"value":249,"state":104,"qualifier":14},{"value":103,"state":104,"qualifier":14},{"field":380,"from":381,"to":383,"delta":385},"estate_claims",{"value":382,"state":104,"qualifier":14},820,{"value":384,"state":104,"qualifier":14},248327.33,247507.33,{"field":387,"from":388,"to":390,"delta":392},"estate_account_balance",{"value":389,"state":104,"qualifier":14},285544.57,{"value":391,"state":104,"qualifier":14},164753.98,-120790.59,[394,399,404,408],{"kind":395,"id":344,"title":346,"report_number":14,"date":396,"pages":185,"category":129,"url":14,"publication_type":345,"publication_number":397,"stored_at":341,"download_url":398},"publication","2026-09-30","01.obr.25.159.F.1316.1.26","https:\u002F\u002Ffaillissement.app\u002Fapi\u002Fcases\u002Flead-pharma-medicine-bv-09172969\u002Fpublications\u002F01M3SJFSM4FTZCD4RW2MVXCTP3\u002Fdownload",{"kind":400,"id":401,"title":359,"report_number":14,"report_date":73,"date":73,"pages":402,"category":129,"url":403},"report","01M3SJG816Q8VPXB9KRPS86W8P",10,"https:\u002F\u002Ffaillissement.app\u002Fdocuments\u002F01M3SJG816Q8VPXB9KRPS86W8P.pdf",{"kind":395,"id":364,"title":366,"report_number":14,"date":405,"pages":185,"category":129,"url":14,"publication_type":365,"publication_number":406,"stored_at":341,"download_url":407},"2026-05-13","01.obr.25.159.F.1308.1.26","https:\u002F\u002Ffaillissement.app\u002Fapi\u002Fcases\u002Flead-pharma-medicine-bv-09172969\u002Fpublications\u002F01M3SJFSM3Z6MEWKZGNM4HV5W9\u002Fdownload",{"kind":400,"id":171,"title":172,"report_number":105,"report_date":106,"date":106,"pages":173,"category":129,"url":174},{"official":58,"curator":60,"automated":410,"external":60},74,[],[]]